Eom Pharmaceutical Holdings Inc (IMUC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,124 | -4,974 | -14,495 | -14,979 | -14,341 |
| Depreciation Amortization | 22 | 11 | 46 | 34 | 23 |
| Accounts payable and accrued liabilities | -404 | -27 | -401 | 91 | -560 |
| Other Working Capital | 33 | -44 | -1,104 | -12 | -1,084 |
| Other Operating Activity | 1,356 | 2,827 | 3,574 | 5,678 | 9,073 |
| Operating Cash Flow | $-4,118 | $-2,207 | $-12,380 | $-9,188 | $-6,889 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -34 | N/A | -10 | -6 | -6 |
| Investing Cash Flow | $-34 | $N/A | $-10 | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 404 | N/A | 28,731 | 9,371 | 9,371 |
| Common Stock Repurchased | 84 | 84 | 21 | 21 | 11 |
| Other Financing Activity | 2,900 | 11 | 3,202 | 3,154 | 2,199 |
| Financing Cash Flow | $3,388 | $95 | $31,953 | $12,546 | $11,582 |
| Beginning Cash Position | 26,217 | 26,217 | 6,653 | 6,653 | 6,653 |
| End Cash Position | 25,452 | 24,104 | 26,217 | 10,006 | 11,340 |
| Net Cash Flow | $-764 | $-2,112 | $19,564 | $3,353 | $4,687 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,118 | -2,207 | -12,380 | -9,188 | -6,889 |
| Capital Expenditure | -34 | N/A | -10 | -6 | -6 |
| Free Cash Flow | -4,152 | -2,207 | -12,390 | -9,193 | -6,895 |